Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B
Clinical trial NCT05808374 · UNKNOWN
Trial details
- NCT number
- NCT05808374
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-30
- Primary completion
- 2024-05-31
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.